NYSE$TDOC
Teladoc Health Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Teladoc Health's third quarter earnings increased as revenue grew year-over-year and total visits increased.
Teladoc Health reported strong third-quarter results with revenue growing 81% year-over-year to $522 million. Total third quarter visits topped 3.9 million, a 37% increase from Q3 2020. The company updated its 2021 revenue outlook to $2,015 million to $2,025 million.
- Third quarter revenue grew 81% year-over-year to $522 million.
- Total third quarter visits topped 3.9 million – 37% higher than Q3 2020.
- New agreements with CVS Health and Centene to provide Teladoc Health’s Primary360.
- Teladoc Health ranked 1st in consumer satisfaction by J.D. Power 2021 U.S. Telehealth Satisfaction Study.
Headline financials
Revenue & EPS history
Teladoc · Revenue · Quarterly
$522M
Revenue by segment
Teladoc · $660M total across 2 segments · Q3 2023
- Integrated Care$374M—56.7%
- BetterHelp$286M—43.3%
Forward guidance
Teladoc Health provides guidance based on current market conditions and expectations. For the fourth-quarter 2021, we expect: Total revenue to be in the range of $536 million to $546 million.
Tailwinds
- Total revenue to be in the range of $536 million to $546 million.
- EBITDA to be in the range of $(8) million to $(3) million.
- Adjusted EBITDA to be in the range of $69 million to $74 million.
- Net loss per share, based on 160 million weighted average shares outstanding, to be between $(0.73) and $(0.53).
- Total U.S. paid membership to be in the range of 52.5 million to 53.5 million members and visit fee only access to be available to approximately 23 million to 24 million individuals.
Headwinds
- Net loss per share, based on 160 million weighted average shares outstanding, to be between $(0.73) and $(0.53).
- EBITDA to be in the range of $(8) million to $(3) million.
- Total revenue to be in the range of $2,015 million to $2,025 million.
- EBITDA to be in the range of $(80) million to $(75) million.
- Net loss per share, based on 157 million weighted average shares outstanding, to be between $(3.40) and $(3.20).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-1.2%
Avg return
Earnings day
-2.1%
Avg return
5 days after
-1.6%
Avg return
30 days after
49%
21 / 43 earnings
Positive
+23.7%
Q2 2023
Best reaction
-42.0%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.8% | +11.9% | +27.9% | |
| Q4 2025 | +15.5% | +9.7% | +10.5% | |
| Q3 2025 | +6.2% | -3.0% | -7.8% | |
| Q1 2025 | -2.8% | -5.7% | -3.8% | |
| Q4 2024 | -13.6% | -16.3% | -26.4% | |
| Q3 2024 | +0.9% | -0.6% | +34.3% | |
| Q2 2024 | -11.7% | -21.9% | -26.3% | |
| Q1 2024 | -5.2% | -7.1% | -16.4% | |
| Q4 2023 | -25.6% | -31.1% | -27.3% | |
| Q3 2023 | -3.3% | -13.5% | -5.3% | |
| Q2 2023 | +23.7% | +20.9% | -6.1% | |
| Q1 2023 | +3.4% | +2.2% | -14.4% | |
| Q4 2022 | -3.9% | -5.4% | -12.2% | |
| Q3 2022 | +6.4% | +10.8% | +3.2% | |
| Q2 2022 | -11.4% | -8.4% | -20.1% | |
| Q1 2022 | -42.0% | -35.7% | -38.1% | |
| Q4 2021 | -5.4% | +8.8% | +6.8% | |
| Q3 2021 | +5.6% | +7.2% | -22.4% | |
| Q2 2021 | +1.4% | -0.9% | -5.5% | |
| Q1 2021 | -10.1% | -14.1% | -20.7% | |
| Q4 2020 | -14.2% | -12.7% | -30.9% | |
| Q3 2020 | -2.3% | -14.6% | -11.9% | |
| Q2 2020 | +11.5% | +11.5% | -1.9% | |
| Q1 2020 | -9.1% | -3.8% | -3.9% | |
| Q4 2019 | +14.1% | +5.1% | +38.6% | |
| Q3 2019 | +7.1% | +12.3% | +17.1% | |
| Q2 2019 | +1.9% | -6.5% | -17.5% | |
| Q1 2019 | -2.0% | +2.9% | -1.8% | |
| Q4 2018 | -4.5% | -6.3% | -17.5% | |
| Q3 2018 | +4.6% | -8.6% | -9.9% | |
| Q2 2018 | +9.0% | +10.3% | +29.6% | |
| Q1 2018 | +5.7% | -1.9% | +18.4% | |
| Q4 2017 | +4.0% | +8.8% | +4.5% | |
| Q3 2017 | -3.0% | -5.4% | +8.0% | |
| Q2 2017 | -7.1% | -2.6% | +5.5% | |
| Q1 2017 | +23.3% | +26.9% | +46.3% | |
| Q4 2016 | +6.8% | -4.8% | +13.4% | |
| Q3 2016 | +6.2% | +8.6% | +19.4% | |
| Q2 2016 | -16.1% | -9.0% | +2.9% | |
| Q1 2016 | -1.5% | — | — | |
| Q4 2015 | -7.3% | — | — | |
| Q3 2015 | -10.6% | — | — | |
| Q2 2015 | +3.6% | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro